TELESCOPE- TELEhealth Shared Decision-making COaching

Description

Hypothesis 1a: The investigators anticipate that navigator decision coaching, compared to enhanced usual care (EUC) will result in higher quality SDM for lung cancer screening (LCS )(primary outcome), greater knowledge of lung cancer screening benefits and harms, and lower decisional conflict. Hypothesis 1b: Compared to enhanced usual care (EUC), we expect that TELESCOPE will result in more screening discussions, increased initial for lung cancer screening (LCS) with low-dose CT scan (LDCT) uptake among interested participants, increased adherence to repeat LCS and diagnostic testing, and increased smoking cessation referrals for current smokers. Hypothesis 2: The investigators expect that a "booster" coaching session will increase adherence to repeat lung cancer screening (LCS).

Conditions

Lung Neoplasms

Talk to us

Study Overview

On this page

Study Details

Study overview

Hypothesis 1a: The investigators anticipate that navigator decision coaching, compared to enhanced usual care (EUC) will result in higher quality SDM for lung cancer screening (LCS )(primary outcome), greater knowledge of lung cancer screening benefits and harms, and lower decisional conflict. Hypothesis 1b: Compared to enhanced usual care (EUC), we expect that TELESCOPE will result in more screening discussions, increased initial for lung cancer screening (LCS) with low-dose CT scan (LDCT) uptake among interested participants, increased adherence to repeat LCS and diagnostic testing, and increased smoking cessation referrals for current smokers. Hypothesis 2: The investigators expect that a "booster" coaching session will increase adherence to repeat lung cancer screening (LCS).

TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary carE (TELESCOPE)

TELESCOPE- TELEhealth Shared Decision-making COaching

Condition
Lung Neoplasms
Intervention / Treatment

-

Contacts and Locations

New Brunswick

Rutgers, Cancer Institute of New Jersey, New Brunswick, New Jersey, United States, 08901

Houston

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Be 50 to 77 years of age
  • * Be a current or former smoker having quit within the past 15 years
  • * Have at least a 20 pack-year smoking history
  • * Be scheduled for a non-acute care visit at one of the study sites. Interviews (N=50)
  • * A practicing primary care clinician or a clinic director (n=20), nursing director, or clinic practice administrator (n=20) at one of the participating sites or a TELESCOPE study patient navigator (n=7) and nurse navigator (n = 3)
  • * Age 18 or older
  • * Fluent in English Online surveys (N=130)
  • * A practicing primary care provider at one of the participating sites or a TELESCOPE study navigator
  • * Age 18 or older
  • * Fluent in English
  • * Do not speak English
  • * Have a history lung cancer
  • * Were screened for lung cancer within the past 12 months
  • * Have health conditions that make them poor candidates for curative treatment as determined by the primary care provider
  • * Are unable to provide informed consent Interviews (N=50)
  • * Are unable to provide informed consent Online surveys (N=130)
  • * Are unable to provide informed consent
  • * Women who are pregnant. English proficiency is required for the completion of surveys, and the intervention will be conducted in English.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Rutgers, The State University of New Jersey,

Anita Y Kinney, PhD, RN, PRINCIPAL_INVESTIGATOR, Rutgers Cancer Institute of New Jersey

Study Record Dates

2027-12-31